tirofiban has been researched along with Arterial Occlusive Diseases in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 4 (36.36) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, W; Lei, B; Li, F; Li, H; Liu, W; Nogueira, RG; Qiu, Z; Sang, H; Saver, JL; Yang, Q; Zhang, M; Zhou, P; Zhou, Z; Zi, W | 1 |
| Chen, W; Li, T; Li, Z; Liu, J; Wang, S; Xing, P; Yang, P; Zhang, L; Zhang, Y | 1 |
| Bai, Y; Cao, W; Chang, M; Chen, S; Dai, W; Deng, W; Du, J; Fu, X; Ge, H; Guo, F; Guo, Z; Hong, Y; Hu, J; Hu, W; Hu, Z; Huang, C; Huang, J; Huang, W; Huang, X; Jiang, S; Jin, Y; Jin, Z; Ju, D; Ke, Y; Kong, W; Lei, B; Li, F; Li, H; Li, J; Li, L; Li, R; Liu, S; Liu, T; Liu, W; Long, C; Lu, M; Luo, J; Luo, S; Luo, W; Luo, X; Miao, J; Nogueira, RG; Pan, C; Peng, D; Pu, J; Qi, L; Qiu, Z; Sang, H; Saver, JL; Shi, Z; Song, B; Song, J; Sun, D; Sun, Y; Tian, Y; Tian, Z; Wan, Y; Wang, J; Wang, L; Wang, S; Wang, T; Wang, Y; Wei, L; Wen, C; Wen, H; Wu, D; Wu, J; Wu, Y; Xu, X; Yan, Z; Yang, J; Yang, Q; Yang, S; Yu, Y; Yuan, G; Yuan, J; Yuan, Z; Yue, C; Zeng, G; Zeng, H; Zhang, G; Zhang, J; Zhang, M; Zhang, S; Zhao, W; Zheng, B; Zheng, C; Zhou, P; Zhou, Z; Zhu, X; Zi, W | 1 |
| Fei, Y; Lin, S; Lin, Y; Pan, X; Xu, M; Yang, J; Zou, J | 1 |
| Lee, DH; Sung, JH; Yi, HJ | 1 |
| Ballotta, E; Baracchini, C; Causin, F; Cester, G; Farina, F; Favaretto, S; Kulyk, C; Nico, L; Palmieri, A; Soso, M; Viaro, F | 1 |
| Chen, TW; Huang, H; Jiang, L; Liu, KQ; Sang, HF; Si, XL; Xia, WQ; Yin, CG | 1 |
| Aytemir, K; Canpolat, U; Yorgun, H | 1 |
| Glahn, J; Philipps, J; Rother, J; Schwarze, M; Thomalla, G | 1 |
| Erkoc, R; Eryonucu, B; Tuncer, M | 1 |
| Cucchiara, BL; Hurst, RW; Liebeskind, DS; McGarvey, ML; Pollard, JR; Schwartz, ED | 1 |
4 trial(s) available for tirofiban and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Endovascular treatment with versus without tirofiban for stroke patients with large vessel occlusion: The multicenter, randomized, placebo-controlled, double-blind RESCUE BT study protocol.
Topics: Arterial Occlusive Diseases; Double-Blind Method; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Stroke; Tirofiban; Treatment Outcome; Tyrosine | 2022 |
Endovascular Recanalization for Acute Internal Carotid Artery Terminus Occlusion: A Subgroup Analysis From the Direct-MT Trial.
Topics: Arterial Occlusive Diseases; Carotid Artery Diseases; Carotid Artery, Internal; Endovascular Procedures; Humans; Retrospective Studies; Stroke; Tirofiban; Treatment Outcome | 2022 |
Effect of Intravenous Tirofiban vs Placebo Before Endovascular Thrombectomy on Functional Outcomes in Large Vessel Occlusion Stroke: The RESCUE BT Randomized Clinical Trial.
Topics: Administration, Intravenous; Aged; Arterial Occlusive Diseases; Brain Ischemia; Double-Blind Method; Endovascular Procedures; Female; Humans; Intracranial Hemorrhages; Ischemic Stroke; Male; Platelet Aggregation Inhibitors; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2022 |
Treatment of progressive stroke with tirofiban--experience in 35 patients.
Topics: Aged; Arterial Occlusive Diseases; Disease Progression; Female; Humans; Injections, Intravenous; Male; Microcirculation; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Stroke; Tirofiban; Treatment Outcome; Tyrosine | 2009 |
7 other study(ies) available for tirofiban and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Influence of tirofiban on stroke outcome after mechanical thrombectomy in acute vertebrobasilar artery occlusion.
Topics: Arterial Occlusive Diseases; Arteries; Brain Ischemia; Cerebral Hemorrhage; Hospital Mortality; Humans; Ischemic Stroke; Retrospective Studies; Stroke; Thrombectomy; Tirofiban; Treatment Outcome | 2022 |
Safety and Efficacy of Intra-arterial Tirofiban Injection During Mechanical Thrombectomy for Large Artery Occlusion.
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Female; Fibrinolytic Agents; Humans; Injections, Intra-Arterial; Male; Middle Aged; Retrospective Studies; Stents; Thrombectomy; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome | 2019 |
Stentriever Thrombectomy Failure: A Challenge in Stroke Management.
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Carotid Artery Diseases; Cerebral Angiography; Computed Tomography Angiography; Endovascular Procedures; Female; Fibrinolytic Agents; Humans; Infarction, Middle Cerebral Artery; Infusions, Intra-Arterial; Intracranial Hemorrhages; Magnetic Resonance Angiography; Male; Middle Aged; Mortality; Prospective Studies; Stents; Stroke; Thrombectomy; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Failure; Treatment Outcome; Tyrosine; Ultrasonography, Doppler, Transcranial | 2017 |
Mechanical Thrombectomy Using Solitaire in Acute Ischemic Stroke Patients with Vertebrobasilar Occlusion: A Prospective Observational Study.
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Female; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Logistic Models; Male; Middle Aged; Multivariate Analysis; Postoperative Hemorrhage; Prognosis; Prospective Studies; Stroke; Thrombectomy; Time-to-Treatment; Tirofiban; Tomography, X-Ray Computed; Vertebrobasilar Insufficiency | 2019 |
Treatment of Sinus Node Artery Occlusion During Anterior Left Atrial Tachycardia Ablation Using Intracoronary Tirofiban.
Topics: Arterial Occlusive Diseases; Catheter Ablation; Coronary Vessels; Female; Fibrinolytic Agents; Humans; Middle Aged; Tachycardia; Tirofiban | 2019 |
Repetitive profound thrombocytopenia after treatment with tirofiban: a case report.
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Drug Administration Schedule; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Thrombocytopenia; Ticlopidine; Tirofiban; Tyrosine | 2004 |
Vertebrobasilar thrombolysis with intravenous tirofiban: case report.
Topics: Aged; Arterial Occlusive Diseases; Fibrinolytic Agents; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stroke; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Tyrosine; Vertebrobasilar Insufficiency | 2002 |